Receptor News and Research

RSS

Study uncovers an over-looked mechanism that likely contributes to autosomal dominant polycystic kidney disease

Autosomal dominant polycystic kidney disease (ADPKD) is a common genetic condition that can lead to kidney failure and that has no cure.

13 Jul 2022

The impact of the SARS-CoV-2 spike A222V mutation on viral infection

Researchers analyzed the structural function of the genetic background of SARS-CoV-2 in the appearance and persistence of A222V spike mutation.

13 Jul 2022

Immunoglobulin G isotypes switch class following repeated SARS-CoV-2 mRNA vaccination

Researchers reported a class switch in SARS-CoV-2-specific antibodies due to repeated mRNA vaccinations.

13 Jul 2022

Production of anti-SARS-CoV-2 antibodies from hyperimmunized chickens

A new study reports the production of neutralizing antibodies against SARS-CoV-2 in hyperimmunized hens.

12 Jul 2022

Scientists explore antigenic imprinting in SARS-CoV-2

A recently published study compared monoclonal RBD antibody responses induced by SARS-CoV-2 Beta variant infections to antibodies induced by the ancestral virus in immunologically naive subjects.

12 Jul 2022

Scientists determine the binding affinity of anti-SARS-CoV-2 antibodies in response to infection or vaccination

Scientists measured the quantity and binding affinity (avidity) of antibodies against five different viral proteins.

12 Jul 2022

What is the long-term protection against COVID-19?

A new study describes the immunologic parameters associated with protection from COVID-19.

12 Jul 2022

Stinging nettle extract inhibits SARS-CoV-2 cell fusion

In a recent study posted to the bioRxiv* preprint server, researchers at Ghent University and KU Leuven, Belgium, demonstrated that Urtica dioica agglutinin (UDA), a monomeric lectin extracted from stinging nettle rhizomes, inhibited severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants of concern (VOCs) cell to cell fusion.

12 Jul 2022

Scientists investigate impact of SARS-CoV-2 RBD mutations across variants

In a recent study posted to the medRxiv* pre-print server, Australian researchers comprehensively investigated the impact of 39 receptor-binding-domain (RBD) mutations in six severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants of concern (VOCs) and variants of interest (VOIs).

12 Jul 2022

Persistence of SARS-CoV-2 in tissues leads to long COVID

PASC is likely the result of long-term persistence of SARS-CoV-2 in various tissues

11 Jul 2022

Commonly prescribed class of migraine drugs may be effective in treating obesity

Triptans, a commonly prescribed class of migraine drugs, may also be useful in treating obesity, a new study by scientists at UT Southwestern suggests.

11 Jul 2022

UT Southwestern researchers reveal the physical mechanism behind a neurological autoimmune disease

Using UT Southwestern's Cryo-Electron Microscopy Facility, researchers for the first time have captured images of an autoantibody bound to a nerve cell surface receptor, revealing the physical mechanism behind a neurological autoimmune disease.

11 Jul 2022

SARS-CoV-2 spike protein downregulates ACE2 expression

In a new study, researchers observed the downregulation of ACE2 by SARS-CoV-2.

11 Jul 2022

Study assesses the potential of plant secondary metabolites as potential anti-COVID-19 agents

A new study has focused on identifying plant secondary metabolites (PSM) having a higher affinity for S-RBD of SARS-CoV-2.

11 Jul 2022

Scientists gain unprecedented insight into the key properties of antibody needed to combat cancer

Researchers at the University of Southampton have gained unprecedented new insight into the key properties of an antibody needed to fight off cancer.

8 Jul 2022

Commercial antibodies do not recognize immune receptor ACKR1

Antibodies are among the most frequently used tools in the biosciences, as they enable researchers to identify molecules.

8 Jul 2022

Researchers unravel the functioning of antibodies in autoimmune encephalitis

Using a state-of-the-art method, researchers at DZNE and the University of Texas have succeeded for the first time at unraveling the effects of autoimmune antibodies, that are directed against the brain, in detail at the atomic level.

8 Jul 2022

Characterization of longer-term effects on behavior and brain inflammation following recovery from mild COVID-19

A recent study reported that long COVID in mice causes brain inflammation and cognitive impairment.

8 Jul 2022

The putative impact of vitamin D receptor gene polymorphisms on SARS-CoV-2 infection among different variants

Researchers assessed the association between SARS-CoV-2 variants and the vitamin D receptor gene.

8 Jul 2022

Nanoparticle vaccine could protect against animal viruses including future SARS-CoV-2 variants

A recent study published in the Science journal depicted that mosaic receptor-binding domain (RBD) nanoparticles immunize from diverse sarbecovirus challenges, including severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), among animal models.

8 Jul 2022

Receptor News and Research

Study uncovers an over-looked mechanism that likely contributes to autosomal dominant polycystic kidney disease

The impact of the SARS-CoV-2 spike A222V mutation on viral infection

Immunoglobulin G isotypes switch class following repeated SARS-CoV-2 mRNA vaccination

Production of anti-SARS-CoV-2 antibodies from hyperimmunized chickens

Scientists explore antigenic imprinting in SARS-CoV-2

Scientists determine the binding affinity of anti-SARS-CoV-2 antibodies in response to infection or vaccination

What is the long-term protection against COVID-19?

Stinging nettle extract inhibits SARS-CoV-2 cell fusion

Scientists investigate impact of SARS-CoV-2 RBD mutations across variants

Persistence of SARS-CoV-2 in tissues leads to long COVID

Commonly prescribed class of migraine drugs may be effective in treating obesity

UT Southwestern researchers reveal the physical mechanism behind a neurological autoimmune disease

SARS-CoV-2 spike protein downregulates ACE2 expression

Study assesses the potential of plant secondary metabolites as potential anti-COVID-19 agents

Scientists gain unprecedented insight into the key properties of antibody needed to combat cancer

Commercial antibodies do not recognize immune receptor ACKR1

Researchers unravel the functioning of antibodies in autoimmune encephalitis

Characterization of longer-term effects on behavior and brain inflammation following recovery from mild COVID-19

The putative impact of vitamin D receptor gene polymorphisms on SARS-CoV-2 infection among different variants

Nanoparticle vaccine could protect against animal viruses including future SARS-CoV-2 variants

Industry Focus eBook - Forensics & toxicology (2nd edition) eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News